A new form of 'nanosized' aspirin to overcome 'aspirin resistance'
Wednesday, September 4, 2013 - 09:00
in Health & Medicine
Scientists are reporting development of a new form of aspirin—taken daily by about 60 million people in the United States alone to reduce the risk of heart attack and stroke—that could extend aspirin's benefits to people who may not respond to the drug. Their advance toward coping with "aspirin resistance" appears in the journal ACS Nano.